Gene Page: GNAO1
Summary ?
GeneID | 2775 |
Symbol | GNAO1 |
Synonyms | EIEE17|G-ALPHA-o|GNAO |
Description | G protein subunit alpha o1 |
Reference | MIM:139311|HGNC:HGNC:4389|Ensembl:ENSG00000087258|HPRD:00757|Vega:OTTHUMG00000133241 |
Gene type | protein-coding |
Map location | 16q13 |
Pascal p-value | 0.224 |
Sherlock p-value | 0.003 |
TADA p-value | 0.011 |
Fetal beta | -0.889 |
DMG | 1 (# studies) |
eGene | Myers' cis & trans |
Support | G-PROTEIN RELAY G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-CONSENSUS G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-FULL G2Cdb.human_BAYES-COLLINS-MOUSE-PSD-CONSENSUS G2Cdb.human_clathrin G2Cdb.human_mGluR5 G2Cdb.human_Synaptosome G2Cdb.human_TAP-PSD-95-CORE G2Cdb.humanPSD G2Cdb.humanPSP CompositeSet Darnell FMRP targets Potential synaptic genes |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DMG:Nishioka_2013 | Genome-wide DNA methylation analysis | The authors investigated the methylation profiles of DNA in peripheral blood cells from 18 patients with first-episode schizophrenia (FESZ) and from 15 normal controls. | 1 |
DNM:Xu_2012 | Whole Exome Sequencing analysis | De novo mutations of 4 genes were identified by exome sequencing of 795 samples in this study | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Association | A combined odds ratio method (Sun et al. 2008), association studies | 1 | Link to SZGene |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenic,schizophrenias | Click to show details |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 1 | |
Network | Shortest path distance of core genes in the Human protein-protein interaction network | Contribution to shortest path in PPI network: 0.4488 |
Section I. Genetics and epigenetics annotation
DNM table
Gene | Chromosome | Position | Ref | Alt | Transcript | AA change | Mutation type | Sift | CG46 | Trait | Study |
---|---|---|---|---|---|---|---|---|---|---|---|
GNAO1 | chr16 | 56370728 | G | A | NM_020988 NM_138736 | p.227A>T p.227A>T | missense missense | Schizophrenia | DNM:Xu_2012 |
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
cg13936125 | 16 | 56225599 | GNAO1 | -0.023 | 0.25 | DMG:Nishioka_2013 |
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs17029291 | chr3 | 32402138 | GNAO1 | 2775 | 0.02 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0000166 | nucleotide binding | IEA | - | |
GO:0004871 | signal transducer activity | IEA | - | |
GO:0003924 | GTPase activity | TAS | 1899283 | |
GO:0005525 | GTP binding | IEA | - | |
GO:0019001 | guanyl nucleotide binding | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0007212 | dopamine receptor signaling pathway | IEA | dopamine (GO term level: 8) | - |
GO:0009987 | cellular process | IEA | - | |
GO:0007165 | signal transduction | IEA | - | |
GO:0008016 | regulation of heart contraction | IEA | - | |
GO:0007626 | locomotory behavior | IEA | - | |
GO:0006936 | muscle contraction | TAS | 9050846 | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005622 | intracellular | IEA | - |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
ADORA1 | RDC7 | adenosine A1 receptor | - | HPRD | 10521440 |
ADRA2A | ADRA2 | ADRA2R | ADRAR | ALPHA2AAR | ZNF32 | adrenergic, alpha-2A-, receptor | - | HPRD | 7887906 |11732925 |
ADRA2C | ADRA2L2 | ADRA2RL2 | ADRARL2 | ALPHA2CAR | adrenergic, alpha-2C-, receptor | - | HPRD | 1349607 |
CACNA1B | BIII | CACNL1A5 | CACNN | Cav2.2 | calcium channel, voltage-dependent, N type, alpha 1B subunit | Reconstituted Complex | BioGRID | 11395521 |
CRHR1 | CRF-R | CRF1 | CRFR1 | CRH-R1h | CRHR | CRHR1f | corticotropin releasing hormone receptor 1 | - | HPRD,BioGRID | 10598591 |
DCTN2 | DCTN50 | DYNAMITIN | RBP50 | dynactin 2 (p50) | Two-hybrid | BioGRID | 16169070 |
FFAR2 | FFA2R | GPR43 | free fatty acid receptor 2 | - | HPRD | 12711604 |
GPSM2 | LGN | Pins | G-protein signaling modulator 2 (AGS3-like, C. elegans) | - | HPRD | 12925752 |
HRH4 | AXOR35 | BG26 | GPCR105 | GPRv53 | H4 | H4R | HH4R | MGC133027 | histamine receptor H4 | - | HPRD | 10973974 |
HTR1F | 5-HT1F | 5HT6 | HTR1EL | MR77 | 5-hydroxytryptamine (serotonin) receptor 1F | - | HPRD | 11916537 |
NGB | - | neuroglobin | Reconstituted Complex | BioGRID | 12860983 |
OPRD1 | OPRD | opioid receptor, delta 1 | - | HPRD,BioGRID | 8393523 |
OPRM1 | KIAA0403 | MOR | MOR1 | OPRM | opioid receptor, mu 1 | - | HPRD,BioGRID | 8393523 |
PTPRU | FLJ37530 | FMI | GLEPP1 | PCP-2 | PTP | PTP-J | PTP-PI | PTPPSI | PTPRO | PTPU2 | R-PTP-PSI | hPTP-J | protein tyrosine phosphatase, receptor type, U | - | HPRD | 10196137 |
RGS14 | - | regulator of G-protein signaling 14 | - | HPRD | 10926822 |
RGS16 | A28-RGS14 | A28-RGS14P | RGS-R | regulator of G-protein signaling 16 | Reconstituted Complex | BioGRID | 9079700 |
RGS19 | GAIP | RGSGAIP | regulator of G-protein signaling 19 | - | HPRD,BioGRID | 8986788 |
RGS4 | DKFZp761F1924 | MGC2124 | MGC60244 | RGP4 | SCZD9 | regulator of G-protein signaling 4 | - | HPRD,BioGRID | 9660808 |
RGS5 | MST092 | MST106 | MST129 | MSTP032 | MSTP092 | MSTP106 | MSTP129 | regulator of G-protein signaling 5 | - | HPRD,BioGRID | 9079700 |
RGS7 | - | regulator of G-protein signaling 7 | - | HPRD,BioGRID | 9572280 |
RIC8A | MGC104517 | MGC131931 | MGC148073 | MGC148074 | RIC8 | synembryn | resistance to inhibitors of cholinesterase 8 homolog A (C. elegans) | - | HPRD,BioGRID | 12509430 |
S1PR5 | EDG8 | Edg-8 | S1P5 | SPPR-1 | SPPR-2 | sphingosine-1-phosphate receptor 5 | - | HPRD | 11069896 |
SCN8A | CerIII | MED | NaCh6 | Nav1.6 | PN4 | sodium channel, voltage gated, type VIII, alpha subunit | - | HPRD,BioGRID | 10066808 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG LONG TERM DEPRESSION | 70 | 53 | All SZGR 2.0 genes in this pathway |
KEGG MELANOGENESIS | 102 | 80 | All SZGR 2.0 genes in this pathway |
PID ENDOTHELIN PATHWAY | 63 | 52 | All SZGR 2.0 genes in this pathway |
PID LYSOPHOSPHOLIPID PATHWAY | 66 | 53 | All SZGR 2.0 genes in this pathway |
PID ER NONGENOMIC PATHWAY | 41 | 35 | All SZGR 2.0 genes in this pathway |
PID S1P S1P3 PATHWAY | 29 | 24 | All SZGR 2.0 genes in this pathway |
PID S1P S1P4 PATHWAY | 14 | 11 | All SZGR 2.0 genes in this pathway |
PID S1P S1P1 PATHWAY | 21 | 18 | All SZGR 2.0 genes in this pathway |
PID CXCR4 PATHWAY | 102 | 78 | All SZGR 2.0 genes in this pathway |
PID S1P META PATHWAY | 21 | 14 | All SZGR 2.0 genes in this pathway |
PID AR NONGENOMIC PATHWAY | 31 | 27 | All SZGR 2.0 genes in this pathway |
PID HEDGEHOG GLI PATHWAY | 48 | 35 | All SZGR 2.0 genes in this pathway |
PID CXCR3 PATHWAY | 43 | 34 | All SZGR 2.0 genes in this pathway |
PID THROMBIN PAR1 PATHWAY | 43 | 32 | All SZGR 2.0 genes in this pathway |
PID S1P S1P2 PATHWAY | 24 | 19 | All SZGR 2.0 genes in this pathway |
REACTOME SIGNALING BY GPCR | 920 | 449 | All SZGR 2.0 genes in this pathway |
REACTOME INTEGRATION OF ENERGY METABOLISM | 120 | 84 | All SZGR 2.0 genes in this pathway |
REACTOME OPIOID SIGNALLING | 78 | 56 | All SZGR 2.0 genes in this pathway |
REACTOME PLC BETA MEDIATED EVENTS | 43 | 32 | All SZGR 2.0 genes in this pathway |
REACTOME G PROTEIN ACTIVATION | 27 | 15 | All SZGR 2.0 genes in this pathway |
REACTOME REGULATION OF INSULIN SECRETION | 93 | 65 | All SZGR 2.0 genes in this pathway |
REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | 25 | 15 | All SZGR 2.0 genes in this pathway |
VECCHI GASTRIC CANCER EARLY DN | 367 | 220 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781 | 1082 | All SZGR 2.0 genes in this pathway |
ROYLANCE BREAST CANCER 16Q COPY NUMBER DN | 26 | 19 | All SZGR 2.0 genes in this pathway |
DARWICHE SKIN TUMOR PROMOTER UP | 142 | 96 | All SZGR 2.0 genes in this pathway |
DARWICHE PAPILLOMA RISK LOW DN | 165 | 107 | All SZGR 2.0 genes in this pathway |
DARWICHE PAPILLOMA RISK HIGH DN | 180 | 110 | All SZGR 2.0 genes in this pathway |
DARWICHE SQUAMOUS CELL CARCINOMA DN | 181 | 107 | All SZGR 2.0 genes in this pathway |
EBAUER TARGETS OF PAX3 FOXO1 FUSION UP | 207 | 128 | All SZGR 2.0 genes in this pathway |
ROVERSI GLIOMA COPY NUMBER DN | 54 | 37 | All SZGR 2.0 genes in this pathway |
DARWICHE PAPILLOMA RISK HIGH VS LOW DN | 32 | 21 | All SZGR 2.0 genes in this pathway |
WATTEL AUTONOMOUS THYROID ADENOMA UP | 73 | 47 | All SZGR 2.0 genes in this pathway |
PUJANA ATM PCC NETWORK | 1442 | 892 | All SZGR 2.0 genes in this pathway |
WEI MYCN TARGETS WITH E BOX | 795 | 478 | All SZGR 2.0 genes in this pathway |
BENPORATH ES WITH H3K27ME3 | 1118 | 744 | All SZGR 2.0 genes in this pathway |
MA MYELOID DIFFERENTIATION DN | 44 | 30 | All SZGR 2.0 genes in this pathway |
THEILGAARD NEUTROPHIL AT SKIN WOUND DN | 225 | 163 | All SZGR 2.0 genes in this pathway |
MCCLUNG DELTA FOSB TARGETS 8WK | 47 | 38 | All SZGR 2.0 genes in this pathway |
BLALOCK ALZHEIMERS DISEASE DN | 1237 | 837 | All SZGR 2.0 genes in this pathway |
KAAB HEART ATRIUM VS VENTRICLE UP | 249 | 170 | All SZGR 2.0 genes in this pathway |
ZHENG GLIOBLASTOMA PLASTICITY UP | 250 | 168 | All SZGR 2.0 genes in this pathway |
WANG TUMOR INVASIVENESS UP | 374 | 247 | All SZGR 2.0 genes in this pathway |
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 2 | 86 | 50 | All SZGR 2.0 genes in this pathway |
KAMMINGA SENESCENCE | 41 | 26 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE VIA TP53 GROUP A | 898 | 516 | All SZGR 2.0 genes in this pathway |
GOBERT OLIGODENDROCYTE DIFFERENTIATION DN | 1080 | 713 | All SZGR 2.0 genes in this pathway |
IKEDA MIR30 TARGETS UP | 116 | 87 | All SZGR 2.0 genes in this pathway |
ACEVEDO FGFR1 TARGETS IN PROSTATE CANCER MODEL DN | 308 | 187 | All SZGR 2.0 genes in this pathway |
DURAND STROMA S UP | 297 | 194 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-103/107 | 934 | 940 | 1A | hsa-miR-103brain | AGCAGCAUUGUACAGGGCUAUGA |
hsa-miR-107brain | AGCAGCAUUGUACAGGGCUAUCA | ||||
miR-129-5p | 993 | 999 | 1A | hsa-miR-129brain | CUUUUUGCGGUCUGGGCUUGC |
hsa-miR-129-5p | CUUUUUGCGGUCUGGGCUUGCU | ||||
miR-134 | 1142 | 1149 | 1A,m8 | hsa-miR-134brain | UGUGACUGGUUGACCAGAGGG |
miR-139 | 175 | 181 | 1A | hsa-miR-139brain | UCUACAGUGCACGUGUCU |
hsa-miR-139brain | UCUACAGUGCACGUGUCU | ||||
miR-181 | 1013 | 1019 | 1A | hsa-miR-181abrain | AACAUUCAACGCUGUCGGUGAGU |
hsa-miR-181bSZ | AACAUUCAUUGCUGUCGGUGGG | ||||
hsa-miR-181cbrain | AACAUUCAACCUGUCGGUGAGU | ||||
hsa-miR-181dbrain | AACAUUCAUUGUUGUCGGUGGGUU | ||||
miR-203.1 | 1152 | 1158 | 1A | hsa-miR-203 | UGAAAUGUUUAGGACCACUAG |
miR-218 | 569 | 575 | m8 | hsa-miR-218brain | UUGUGCUUGAUCUAACCAUGU |
miR-30-5p | 1021 | 1028 | 1A,m8 | hsa-miR-30a-5p | UGUAAACAUCCUCGACUGGAAG |
hsa-miR-30cbrain | UGUAAACAUCCUACACUCUCAGC | ||||
hsa-miR-30dSZ | UGUAAACAUCCCCGACUGGAAG | ||||
hsa-miR-30bSZ | UGUAAACAUCCUACACUCAGCU | ||||
hsa-miR-30e-5p | UGUAAACAUCCUUGACUGGA | ||||
miR-326 | 138 | 144 | m8 | hsa-miR-326 | CCUCUGGGCCCUUCCUCCAG |
miR-330 | 244 | 250 | m8 | hsa-miR-330brain | GCAAAGCACACGGCCUGCAGAGA |
miR-539 | 234 | 241 | 1A,m8 | hsa-miR-539 | GGAGAAAUUAUCCUUGGUGUGU |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.